Terms ending in 2032
Every in-force patent on Valneva SE's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,598,472 | Isolated Polypeptide of the Toxin a and Toxin B Proteins of C. Difficile and Uses Thereof In force · High confidence | Valneva USA, Inc. | In force | High confidence | |
| US 9,884,115 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | |
| US 9,895,437 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | |
| US 10,668,146 | Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | |
| US 11,110,170 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | |
| US 12,527,863 | Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence | |
| US 9,913,898 | Aluminum Compounds for Use in Therapeutics and Vaccines In force · High confidence | Valneva Austria GmbH | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Valneva SE.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.